exciting results from cartitude-1: anti-bcma car-t for mm
Published 4 years ago • 311 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
7:42
cartitude-1 results: car-t against bcma in r/r mm
-
4:10
update on cartitude-1: car-t in rrmm
-
1:07
updated results from cartitude-1
-
3:17
anti-bcma car t-cells for mm: durable clinical responses with ide-cel (formerly bb2121)
-
1:25
car-t in mm: karmma, cartitude-1 and evolve
-
2:15
comparison of patient-reported outcomes from cartitude-1 and locommotion
-
1:30
cartitude-1: promising initial results of cilta-cel for myeloma
-
3:28
cartitude-1: a phase 1b/2 study of jnj-4528, a car-t cell therapy directed against bcma
-
2:48
an overview of the current landscape of car t-cell therapy in myeloma
-
7:06
results from car t-cell bb2121 first-in-human trial for r/r mm
-
1:28
cartitude-4: how is car-t opening new avenues for the treatment of r/r myeloma?
-
1:34
cctx-001: a novel car-t therapy for aml
-
2:06
an insight into the sequencing of car-t and bispecifics in myeloma
-
5:44
cilta-cel in r/r myeloma: preliminary results from cartitude-1
-
0:34
an update on the majestec-1 trial: the efficacy of less frequent dosing of teclistamab in rrmm
-
2:45
updated results from an ongoing phase 1 clinical study of bb21217 anti-bcma car t cell therapy
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
3:07
the role of bridging and timing in car-t